skip to primary navigationskip to content

05.03.18 Invitation to a special seminar by Ross Cagan, Icahn School of Medicine at Mt Sinai, New York

last modified Mar 05, 2018 01:58 PM
Come and hear Ross Cagan describe his 'fly-to-bedside' approach of developing therapeutics based on models of disease in Drosophila

Everyone is welcome to attend


Abstract: Our deepening knowledge of the genomic and physiological basis of disease has led to important advances in our understanding of mechanism and of therapeutics. This growing knowledge has also highlighted important challenges including disease complexity in the context of the whole body. I will discuss our use of Drosophila to explore and address this complexity in thyroid and colorectal cancers, including developing lead therapeutic compounds and a fly-to-bedside clinical trial. I will also discuss how our platform can be leveraged to embrace complexity in other diseases that are readily modelled in flies.

Covid 19


The Gurdon Institute closed on Friday 20th March for all but essential activities in order to protect staff from the COVID-19 outbreak.

We can still be contacted by email.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this